COVID-19 in pregnancy: Perinatal outcomes and complications

Table 1 Patient characteristics (n = 60)

Demographics
Age median (IQR)	30 (24-35)
Gestational week median (IQR)	36 (30-38)
Comorbidities (%)
Hypertension	1 (1.66)
Diabetes	3 (5)
Hypothyroidism	5 (8.5)
BMI > 30	3 (5)
Hematologic condition	4 (6.8)
Former OB/GYN pathology	3 (5)
Symptomatology
Days from onset median (IQR)	3 (2-7)
Asymptomatic (%)	27 (45)
Fever (%/symptomatic)	18 (54.5)
Dyspnea (%/symptomatic)	11 (33.3)
Cough (%/symptomatic)	19 (57.6)
Contractions (%/symptomatic)	11 (33.3)
Pregnancy outcomes (%)
Preterm delivery	18 (30)
Fetal clinical abnormalities	4 (6.6)
Neonatal ICU admission	6 (10)
Miscarriage	1 (1.66)
Still birth	2 (3.33)
SGA	3 (5)
CS due to ARDS	2 (3.33)
Maternal outcomes (%)
Hospitalization	15 (25)
Survival	60 (100)
IMV	4 (6.6)
Pharmacologic management (%)
Corticosteroids	25 (41.6)
Remdesivir	13 (21.6)

BMI: Body mass index; OB/GYN: Obstetric/gynecologic; ICU: Intensive care unit; SGA: Small for gestational age; CS: Cesarean section; ARDS: Acute respiratory distress syndrome; IMV: Invasive mechanical ventilation.